• OPEN AN ACCOUNT
Indian Indices
Sensex
81,857.48 319.78
( 0.39%)
Global Indices
Nasdaq
49,444.50 324.78
(0.66%)
Dow Jones
6,973.05 36.44
(0.53%)
Hang Seng
53,322.83 437.58
(0.83%)
Nikkei 225
10,215.77 66.92
(0.66%)
Forex
USD-INR
91.64 0.05
(0.06%)
EUR-INR
108.40 1.13
(1.05%)
GBP-INR
125.02 1.82
(1.48%)
JPY-INR
0.59 0.01
(1.89%)

EQUITY - MARKET SCREENER

Honeywell Automation India Ltd
Industry :  Electronics - Components
BSE Code
ISIN Demat
Book Value()
517174
INE671A01010
4739.2986425
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HONAUT
53.74
27733.02
EPS(TTM)
Face Value()
Div & Yield %
583.82
10
0.33
 

websol energy system ltd
Astrazeneca Pharma and Sun Pharma form second brand partnership
Nov 17,2025
Astrazeneca Pharma India and Sun Pharmaceutical Industries announced a second brand partnership for Sodium Zirconium Cyclosilicate (SZC) in India. This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India. Under the agreement, both companies will promote, market & distribute SZC in India under different brand names; AstraZeneca will market SZC as Lokelma® whereas Sun Pharma will promote and distribute the therapy as Gimliand®. AstraZeneca will retain the intellectual property rights to SZC and hold the Marketing Authorisation along with the import license of the molecule.